Baudax Bio, Inc.
BXRXDelisted Feb 15, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001780097
Baudax Bio, Inc. was delisted on Feb 15, 2024; its insiders filed their last Form 4 on Dec 19, 2022; 15 institutions reported holding it in 13F filings for Q3 2023, worth $74.5K in total; no superinvestor held it.
13F holders, Q4 2023
Institutional positions in Baudax Bio, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
BXRX is no longer listed, and 13F filings after Q3 2023 list far fewer holders. See Q3 2023
- Institutional holders
- 2
- −13 vs. Q3 2023
- Shares held
- 2
- −199.8K (−100.0%) vs. Q3 2023
- Total value
- $0
- −$74.5K (−100.0%) vs. Q3 2023
- New holders
- 0
- 0 more added
- Sold out
- 13
- 0 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BXRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 1 | $0 |
| Q1 2025 | 1 | $0 |
| Q4 2024 | 1 | $0 |
| Q3 2024 | 1 | $0 |
| Q2 2024 | 1 | $0 |
| Q1 2024 | 1 | $0 |
| Q4 2023 | 2 | $0 |
| Q3 2023 | 15 | $74.5K |
| Q2 2023 | 12 | $152.0K |
| Q1 2023 | 12 | $127.0K |
| Q4 2022 | 10 | $73.2K |
| Q3 2022 | 22 | $352.0K |
| Q2 2022 | 22 | $1.08M |
| Q1 2022 | 21 | $2.20M |
| Q4 2021 | 33 | $2.78M |
| Q3 2021 | 31 | $4.12M |
| Q2 2021 | 39 | $5.58M |
| Q1 2021 | 38 | $9.43M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Baudax Bio, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Sittner & Nelson, LLC | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 0 | $0 | 0.00% | −48,300−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −45,363−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −41,888−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −23,426−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −11,602−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −10,834−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −10,699−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −6,844−100.0% | Sold out |
| BlackRock Inc. | 0 | $0 | 0.00% | −797−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −53−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −22−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −1−100.0% | Sold out |